Fourth quarter Adjusted
EBITDA1 of $463 million and full year
Adjusted EBITDA of $1,913 million
Fourth quarter and full year Net earnings per
share of $0.49 and $2.68,
respectively
Annualized dividend increasing $0.04 per share (3 percent) to $1.40 per share
CALGARY,
AB, Feb. 27, 2024 /PRNewswire/ - Parkland
Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI),
today announced its financial and operating results for the three
months and year ended December 31,
2023.
"I want to congratulate the Parkland team on an excellent year,"
said Bob Espey, President and Chief
Executive Officer. "We delivered approximately $300 million of incremental Adjusted EBITDA in
2023 compared to 2022, and have accelerated our $2 billion of Adjusted EBITDA
Guidance2 to 2024, with significantly less invested
capital than expected. We are firmly on track with our ambitious
plan to deliver long-term value to our shareholders, which we
outlined at our Investor Day."
"Parkland continues to progress its Board renewal process,"
added Espey. "I would like to welcome Michael Jennings and James Neate to the Parkland Board of Directors
and am pleased with the recent nomination of Mariame McIntosh Robinson. Each brings
substantial expertise across many areas to Parkland, and their
knowledge and insights will be invaluable."
Q4 2023 Highlights
- Adjusted EBITDA attributable to Parkland ("Adjusted EBITDA") of
$463 million, consistent with the
fourth quarter of 2022.
- Net earnings attributable to Parkland of $86 million ($0.49
per share, basic), an increase of 25 percent from the fourth
quarter of 2022, and Adjusted earnings attributable to Parkland
("Adjusted earnings"2) of $151
million ($0.86 per share,
basic) up 29 percent from the fourth quarter of 2022.
- Available cash flow2 of $181
million, up 53 percent from the fourth quarter of 2022, and
Cash generated from operating activities of $417 million, down 34 percent from the fourth
quarter of 2022, due to favourable non-cash working capital
movements in the prior period.
- Repaid $106 million of our credit
facility with liquidity available3 of $1.3 billion at December
31, 2023.
- Grew JOURNIETM Rewards to 5.8 million members,
reflecting expansion into select International markets and the
launch of our partnership with Aeroplan.
2023 Highlights
- Record Adjusted EBITDA of $1,913
million, up 18 percent from 2022.
- Net earnings attributable to Parkland of $471 million ($2.68
per share, basic), an increase of 52 percent from 2022, and
Adjusted earnings of $626 million
($3.56 per share, basic) up 34
percent from 2022.
- Available cash flow of $812
million ($4.61 per share,
basic), up 15 percent from 2022, and Cash generated from (used in)
operating activities of $1,780
million, up 34 percent from 2022.
- Repaid $747 million of our credit
facility and lowered our Leverage Ratio4 to 2.8 times
(3.4 times at Q4 2022), demonstrating Parkland's ongoing commitment
to deleveraging.
Q4 2023 Segment Highlights
- Canada delivered Adjusted
EBITDA of $190 million, consistent
with Q4 2022 ($197 million). Company
Volume Same Store Sales Growth ("Company Volume SSSG"5)
was 6.9 percent and Food and Company C-Store SSSG (excluding
cigarettes)2 was 1.2 percent. Canada delivered Food and Company C-store
revenue of $92 million, consistent
with Q4 2022 ($88 million).
- International delivered Adjusted EBITDA of $157 million, up 43 percent, from Q4 2022
($110 million). Performance was
primarily driven by additional volumes in our commercial business
and strong fuel unit margins, due to organic growth and synergy
capture.
- USA delivered Adjusted EBITDA
of $39 million, down 15 percent from
Q4 2022 ($46 million). The decrease
was primarily driven by lower fuel unit margins in our commercial
business, partially offset by strong C-Store margins and reduced
Operating costs.
- Refining delivered Adjusted EBITDA of $106 million, down 17 percent, from Q4 2022
($128 million). Composite
utilization5 was 90 percent in Q4 2023, compared to 98
percent in Q4 2022. The decrease was primarily driven by a
third-party power outage.
- Parkland's total recordable injury frequency rate5
on a trailing-twelve-months basis was 1.07, compared to 1.05 at
December 31, 2022.
Enhancing Shareholder Distributions
- Parkland's quarterly dividend will increase from $0.34 to $0.35 per
common share, effective with the quarterly dividend payable on
April 15, 2024 to shareholders of
record at the close of business on March 22,
2024. Dividends are expected to be declared and paid on a
quarterly basis.
- Parkland purchased and cancelled approximately 583,000 Parkland
common shares for $26 million under
its normal course issuer bid ("NCIB") program in Q4 2023.
Additionally, Parkland repurchased approximately 700,000 common
shares for $31 million in
January 2024 under its automatic
share purchase plan. Parkland's disciplined capital allocation
framework balances deleveraging, organic growth, and enhancing
shareholder returns and the Company expects to continue to
opportunistically utilize its NCIB program.
___________________________________
|
1
|
Total of segments
measure. See "Total of Segments Measures" section of this news
release.
|
2
|
Non-GAAP financial
measure or non-GAAP financial ratio. See "Non-GAAP Financial
Measures and Ratios" section of this news release.
|
3
|
Supplementary financial
measure. See "Supplementary Financial Measures" section of this
news release.
|
4
|
Capital management
measure. See "Capital Management Measures" section of this news
release.
|
5
|
Non-financial measure.
See "Non-Financial Measures" section of this news
release.
|
Refinery Update
Following an initial shut down due to extreme cold weather in
mid-January, a technical issue with a processing unit led to an
unplanned outage beginning January 21,
2024. We have completed inspection and repair work,
including maintenance activities previously scheduled for
February 2024. We expect to resume
normal operations in early March
2024, with the total refinery outage to be approximately
eight weeks during the first quarter of 2024.
We have developed a robust recovery plan and expect to meet our
2024 Adjusted EBITDA Guidance range of $1.95 to $2.05
billion. Plans include enhanced refinery operations and
optimized refinery supply, as well as ongoing operating and
MG&A cost reductions across the business.
Consolidated Financial Overview
($ millions, unless
otherwise noted)
|
Three months ended
December 31,
|
Year ended
December 31,
|
Financial
Summary
|
2023
|
2022
|
2023
|
2022
|
Sales and operating
revenue
|
7,746
|
8,719
|
32,452
|
35,462
|
Adjusted EBITDA
attributable to Parkland ("Adjusted
EBITDA")(1)
|
463
|
455
|
1,913
|
1,620
|
Canada
|
190
|
197
|
713
|
702
|
International
|
157
|
110
|
678
|
383
|
USA
|
39
|
46
|
186
|
126
|
Refining
|
106
|
128
|
441
|
516
|
Corporate
|
(29)
|
(26)
|
(105)
|
(107)
|
Net earnings (loss)
attributable to Parkland
|
86
|
69
|
471
|
310
|
Net earnings (loss) per
share – basic ($ per share)
|
0.49
|
0.39
|
2.68
|
1.94
|
Net earnings (loss) per
share – diluted ($ per share)
|
0.48
|
0.39
|
2.63
|
1.92
|
Trailing-twelve-month
("TTM") Cash generated from (used in) operating
activities(2)
|
1,780
|
1,326
|
1,780
|
1,326
|
TTM Cash generated from
(used in) operating activities per share(2)
|
10.13
|
8.29
|
10.13
|
8.29
|
TTM available cash
flow(3)
|
812
|
708
|
812
|
708
|
TTM available cash flow
per share(3)
|
4.61
|
4.43
|
4.61
|
4.43
|
TTM Return on invested
capital(3)
|
9.8 %
|
8.4 %
|
9.8 %
|
8.4 %
|
(1) Total of segments
measure. See "Total of Segments Measures" section of this news
release.
|
(2) Supplementary
financial measure. See "Supplementary Financial Measures" section
of this news release.
|
(3) Non-GAAP
financial measure or non-GAAP financial ratio. See Section 17 of
the Q4 2023 MD&A.
|
Q4 2023 Conference Call and Webcast Details
Parkland will host a webcast and conference call on Wednesday, February 28, 2024 at 6:30 am MT (8:30 am
ET) to discuss the results. To listen to the live webcast
and watch the presentation, please use the following link:
https://app.webinar.net/VAjLrA2Y10R
Analysts and investors interested in participating in the
question and answer session of the conference call may do so by
calling 1-888-390-0546 (toll-free) (Conference ID: 97733547).
International participants may call 1-800-389-0704 (toll-free)
(Conference ID: 97733547).
Please connect and log in approximately 10 minutes before the
beginning of the call. The webcast will be available for replay two
hours after the conference call ends at the link above. It will
remain available for one year and will also be posted at
http://www.parkland.ca.
Annual General Meeting of Shareholders
Parkland will host its 2024 Annual General Meeting of
Shareholders on Thursday, March 28,
2024, at 9:00 am MT (11:00
am ET). The meeting will be held at The Westin Calgary hotel
in Calgary, Alberta.
Parkland's Management Information Circular is available at
www.parkland.ca and under Parkland's profile at
www.sedarplus.ca.
MD&A and Annual Consolidated Financial Statements
The Management's Discussion and Analysis for the year ended
December 31, 2023 (the "Q4 2023
MD&A") and Annual Consolidated Financial Statements for the
year ended December 31, 2023 (the
"2023 Annual Consolidated Financial Statements") provide a detailed
explanation of Parkland's operating results for the year ended
December 31, 2023. An English version
of these documents will be available online at
www.parkland.ca and the System for Electronic Data Analysis
and Retrieval + ("SEDAR+") after the results are released by
newswire under Parkland's profile at www.sedarplus.ca. The French
versions of the Q4 2023 MD&A and the 2023 Annual Consolidated
Financial Statements will be posted to www.parkland.ca and
SEDAR+ as soon as they become available.
About Parkland Corporation
Parkland is an international fuel distributor, marketer, and
convenience retailer with operations in 26 countries across the
Americas. We serve over one million customers each day. Our retail
network meets the fuel and convenience needs of everyday consumers.
Our commercial operations provide businesses with industrial fuels
so that they can better serve their customers. In addition to
meeting our customers' needs for essential fuels, we provide a
range of choices to help them lower their environmental impact.
These include renewable fuels sourcing, manufacturing and blending,
carbon and renewables trading, solar power, and ultra-fast EV
charging. With approximately 4,000 retail and commercial locations
across Canada, the United States and the Caribbean region, we have developed supply,
distribution and trading capabilities to accelerate growth and
business performance.
Our strategy is focused on two pillars: our Customer Advantage
and our Supply Advantage. Through our Customer Advantage, we aim to
be the first choice of our customers, cultivating their loyalty
through proprietary brands, differentiated offers, our extensive
network, competitive pricing, reliable service, and our compelling
loyalty program. Our Supply Advantage is based on achieving the
lowest cost to serve among independent fuel marketers and
distributors in the hard-to-serve markets in which we operate,
through our well-positioned assets, significant scale, and deep
supply and logistics capabilities. Our business is underpinned by
our people and our values of safety, integrity, community and
respect, which are deeply embedded across our organization.
Forward-Looking Statements
Certain statements contained herein constitute forward-looking
information and statements (collectively, "forward-looking
statements"). When used in this news release, the words "expect",
"will", "could", "would", "believe", "continue", "pursue" and
similar expressions are intended to identify forward-looking
statements. In particular, this news release contains
forward-looking statements with respect to, among other things:
business strategies, objectives and initiatives; Parkland's 2024
Adjusted EBITDA Guidance; Parkland's expectations regarding the
Burnaby Refinery outage and resuming operations at the Burnaby
Refinery, including the timing in respect thereof; Parkland's plans
to enhance operations and optimize supply at the Burnaby Refinery;
Parkland's expectations regarding future dividend amounts, and
timing and frequency of payments, and with respect to completing
additional share repurchases, if any, using its NCIB program; and
Parkland's plans to implement ongoing operating and MG&A cost
reductions.
These statements involve known and unknown risks, uncertainties
and other factors that may cause actual results or events to differ
materially from those anticipated in such forward-looking
statements. No assurance can be given that these expectations will
prove to be correct and such forward-looking statements included in
this news release should not be unduly relied upon. These
forward-looking statements speak only as of the date of this news
release. Parkland does not undertake any obligation to publicly
update or revise any forward-looking statements except as required
by securities law. Actual results could differ materially from
those anticipated in these forward-looking statements as a result
of numerous risks and uncertainties, many of which are beyond the
control of Parkland, including, but not limited to: general
economic, market and business conditions; Parkland's ability to
execute its business strategies, objectives, and initiatives,
including the completion, financing and timing thereof, realizing
the benefits therefrom, and meeting our targets and commitments
relating thereto; Parkland's ability to commence restart procedures
and resume normal operations at the Burnaby Refinery successfully
and within the expected timeframe; Parkland's ability to pay future
dividends and complete share repurchases; and the assumptions and
risks described under "Cautionary Statement Regarding
Forward-Looking Information" and "Risk Factors" in Parkland's
Annual Information Form for the year ended December 31, 2023, and under "Forward-Looking
Information" and "Risk Factors" in the Q4 2023 MD&A, which are
incorporated by reference herein, each as filed on SEDAR+ and
available on the Parkland website at http://www.parkland.ca. In
addition, the 2024 Adjusted EBITDA Guidance reflects continued
integration of acquired businesses, synergy capture, and organic
growth initiatives, and the key material assumptions include: an
increase in Retail and Commercial Fuel and petroleum product
adjusted gross margin of approximately 5 percent and Food,
convenience and other adjusted gross margin of approximately 5
percent as compared to the year ended December 31, 2023; the realization of
$100 million of run-rate MG&A
cost efficiencies by the end of 2024; Refining adjusted gross
margin of approximately $41 to
$43 per barrel and average Burnaby
Refinery composite utilization of 80 percent to 85 percent based on
the Burnaby Refinery's crude processing capacity of 55,000 barrels
per day; the impact of the unplanned outage at the Burnaby Refinery
and resumption of normal operations during the first quarter of
2024; enhancements to operations and optimization of supply at the
Burnaby Refinery during 2024; and implementation of ongoing
operating and MG&A cost reductions across the business. The
forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
Specified Financial Measures
This news release contains total of segments measures, non-GAAP
financial measures and non-GAAP financial ratios, supplementary
financial measures and capital management measures (collectively,
"specified financial measures"). Parkland's management uses certain
specified financial measures to analyze the operating and financial
performance, leverage, and liquidity of the business. These
specified financial measures do not have any standardized meaning
under International Financial Reporting Standards ("IFRS") and are
therefore unlikely to be comparable to similar measures presented
by other companies. The specified financial measures should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS. See Section 17 of the Q4 2023 MD&A, which is
incorporated by reference into this news release, for further
details regarding specified financial measures used by
Parkland.
Non-GAAP Financial Measures and Ratios
Adjusted earnings (loss) is a non-GAAP financial measure and
Adjusted earnings (loss) per share is a non-GAAP financial ratio,
each representing the underlying core operating performance of
business activities of Parkland at a consolidated level. The most
directly comparable financial measure to Adjusted earnings (loss)
and Adjusted earnings (loss) per share is Net earnings (loss).
Adjusted earnings (loss) and Adjusted earnings (loss) per share
represent how well Parkland's operational business is performing,
while considering depreciation and amortization, interest on leases
and long-term debt, accretion and other finance costs, and income
taxes. The Company uses these measures because it believes that
Adjusted earnings (loss) and Adjusted earnings (loss) per share are
useful for management and investors in assessing the Company's
overall performance, as they exclude certain significant items that
are not reflective of the Company's underlying business
operations.
See Section 17 of the Q4 2023
MD&A, which is incorporated by reference into this news
release, for the detailed definition and composition of Adjusted
earnings (loss).
Please see below for the reconciliation of Adjusted earnings
(loss) to net earnings (loss) and calculation of Adjusted earnings
(loss) per share.
|
Three months ended
December 31,
|
Year ended
December 31,
|
($ millions, unless
otherwise stated)
|
2023
|
2022
|
2023
|
2022
|
Net earnings (loss)
attributable to Parkland
|
86
|
69
|
471
|
310
|
Add: Net earnings
(loss) attributable to NCI
|
—
|
—
|
—
|
36
|
Net earnings
(loss)
|
86
|
69
|
471
|
346
|
Add:
|
|
|
|
|
Acquisition,
integration and other costs
|
42
|
41
|
146
|
117
|
Loss on modification
of long-term debt
|
—
|
—
|
—
|
2
|
(Gain) loss on foreign
exchange – unrealized
|
—
|
8
|
35
|
(8)
|
(Gain) loss on risk
management and other – unrealized
|
28
|
9
|
(34)
|
39
|
Other (gains) and
losses
|
5
|
(21)
|
3
|
23
|
Other adjusting
items(1)
|
6
|
21
|
48
|
26
|
Tax
normalization(2)
|
(16)
|
(10)
|
(43)
|
(46)
|
Adjusted earnings
(loss) including NCI
|
151
|
117
|
626
|
499
|
Less: Adjusted earnings
(loss) attributable to NCI
|
—
|
—
|
—
|
31
|
Adjusted earnings
(loss) attributable to Parkland ("Adjusted earnings
(loss)")
|
151
|
117
|
626
|
468
|
Weighted average number
of common shares (million shares)(3)
|
176
|
173
|
176
|
160
|
Weighted average number
of common shares adjusted for the effects of dilution (million
shares)(3)
|
180
|
174
|
179
|
161
|
Adjusted earnings
(loss) per share ($ per share)
|
|
|
|
|
Basic
|
0.86
|
0.67
|
3.56
|
2.93
|
Diluted
|
0.84
|
0.67
|
3.50
|
2.91
|
(1)
|
Other adjusting items
for the three months ended December 31, 2023 include: (i) the share
of depreciation, income taxes and other adjustments for investments
in joint ventures and associates of $9 million (2022 - $2 million);
(ii) other income of $2 million (2022 - $4 million); (iii) realized
risk management gain related to underlying physical sales activity
in another period of $2 million (2022 - $7 million loss); (iv)
impact of hyperinflation accounting of $2 million loss (2022 - $1
million gain); (v) adjustment to foreign exchange gains and losses
related to cash pooling arrangements of $1 million (2022 - $1
million); (vi) unrealized risk management gain related to
underlying physical sales activity in current period of nil (2022 -
$10 million); and (vii) loss on inventory write-downs for which
there are offsetting associated risk management derivatives with
unrealized gains of nil (2022 - $2 million). Other adjusting items
for the year ended December 31, 2023 include: (i) other income of
$23 million (2022 - $8 million); (ii) the share of depreciation,
income taxes and other adjustments for investments in joint
ventures and associates of $20 million (2022 - $11 million); (iii)
the effect of market-based performance conditions for
equity-settled share-based award settlements of $13 million (2022 -
nil); (iv) realized risk management gain related to underlying
physical sales activity in another period of $6 million (2022 - $4
million loss); (v) impact of hyperinflation accounting of $2
million loss (2022 - $1 million gain); and (vi) adjustment to
foreign exchange gains and losses related to cash pooling
arrangements of nil (2022 - $2 million).
|
(2)
|
The tax normalization
adjustment was applied to net earnings (loss) adjusting items that
were considered temporary differences, such as acquisition,
integration and other costs, unrealized foreign exchange gains and
losses, unrealized gains and losses on risk management and other,
gains and losses on asset disposals, changes in fair value of
redemption options, changes in estimates of environmental
provisions, loss on inventory write-downs for which there are
offsetting associated risk management derivatives with unrealized
gains, impairments of non-current assets and debt modifications.
The tax impact was estimated using the effective tax rates
applicable to jurisdictions where the related items
occur.
|
(3)
|
Weighted average number
of common shares are calculated in accordance with Parkland's
accounting policy contained in Note 2 of the Annual Consolidated
Financial Statements.
|
Food and Company C-Store SSSG is a non-GAAP financial ratio and
refers to the period-over-period sales growth generated by retail
food and convenience stores at the same Company sites. The effects
of opening and closing stores, temporary closures (including
closures for ON the RUN / Marché Express conversions),
expansions of stores, renovations of stores, and stores with
changes in food service models in the period are excluded to derive
a comparable same-store metric. Same-store sales growth is a metric
commonly used in the retail industry that provides meaningful
information to investors in assessing the health and strength of
Parkland's brands and retail network, which ultimately impacts
financial performance. The most directly comparable financial
measure to Food and Company C-Store SSSG is food and convenience
store revenue within sales and operating revenue. Food and Company
C-Store SSSG does not have any standardized meaning prescribed
under IFRS and is therefore unlikely to be comparable to similar
measures presented by other companies. Please see below for a
reconciliation of convenience store revenue (Food and C-Store
revenue) of the Canada segment
with the Food and Company C-Store same store sales ("SSS") and
calculation of the Food and Company C-Store SSSG.
|
Three months ended
December 31,
|
($ millions)
|
2023
|
2022
|
%(1)
|
Food and Company
C-Store revenue
|
92
|
88
|
|
Add:
|
|
|
|
Point-of-sale ("POS")
value of goods and services sold at Food and Company C-Store
operated by retailers and franchisees(2)(3)
|
324
|
323
|
|
Less:
|
|
|
|
Rental and royalty
income from retailers, franchisees and
other(3)(4)
|
(67)
|
(67)
|
|
Same Store revenue
adjustments(5) (excluding cigarettes)
|
(20)
|
(19)
|
|
Food and Company
C-Store same-store sales
(including cigarettes)
|
329
|
325
|
1.1 %
|
Less:
|
|
|
|
Same Store revenue
adjustments(5) (cigarettes)
|
(102)
|
(100)
|
|
Food and Company
C-Store same-store sales
(excluding cigarettes)
|
227
|
225
|
1.2 %
|
|
Three months ended
December 31,
|
($ millions)
|
2022
|
2021
|
%(1)
|
Food and Company
C-Store revenue
|
88
|
93
|
|
Add:
|
|
|
|
Point-of-sale ("POS")
value of goods and services sold at Food and Company C-Store
operated by retailers(2)
|
306
|
141
|
|
Less:
|
|
|
|
Rental income from
retailers and other(4)
|
(43)
|
(26)
|
|
Same Store revenue
adjustments(4)(5)(6) (excluding cigarettes)
|
(164)
|
(15)
|
|
Food and Company
C-Store same-store sales
(including cigarettes)
|
187
|
193
|
(3.5) %
|
Less:
|
|
|
|
Same Store revenue
adjustments(5)(6) (cigarettes)
|
(87)
|
(99)
|
|
Food and Company
C-Store same-store sales
(excluding cigarettes)
|
100
|
94
|
6.0 %
|
(1)
|
Percentages are
calculated based on actual amounts and are impacted by
rounding.
|
(2)
|
POS values used to
calculate Food and Company C-Store SSSG are not a Parkland
financial measure and do not form part of Parkland's consolidated
financial statements as Parkland earns rental income from retailers
in the form of a percentage rent on convenience store sales. POS
values are calculated based on the information obtained from
Parkland's POS systems at retail sites, including transactional
data, such as sales, costs and volumes, which are subject to
internal controls over financial reporting. We also use this data
to calculate rental income from retailers in the form of a
percentage rent on convenience store sales, which is recorded as
revenue in our consolidated financial statements.
|
(3)
|
Includes the impacts of
acquisitions when the relevant information becomes available after
the completion of the related system integration
activities.
|
(4)
|
Includes rental income
from retailers in the form of a percentage rent on Food and Company
C-Store sales, royalty, franchisee fees and excludes revenues from
automated teller machine, POS system licensing fees, and
other.
|
(5)
|
This adjustment
excludes the effects of acquisitions, opening and closing stores,
temporary closures (including closures for ON the RUN /
Marché Express conversions), expansions of stores, renovations of
stores, and stores with changes in food service models, to derive a
comparable same-store metric.
|
(6)
|
Excludes sales from
acquisitions completed within the year as these will not impact the
metric until after the completion of one year of the acquisitions
when the sales or volume generated establish the baseline for these
metrics.
|
|
|
Available cash flow is a non-GAAP financial measure and
Available cash flow per share is a non-GAAP financial ratio. The
most directly comparable financial measure for Available cash flow
and Available cash flow per share is cash generated from (used in)
operating activities. Parkland uses these measures to monitor its
ability to generate cash flow for capital allocation, including
distributions to shareholders, investment in the growth of the
business, and deleveraging. Available cash flow is calculated as
cash generated from (used in) operating activities adjusted for
items such as (i) net change in (a) non-cash working capital and
(b) other assets and other liabilities, (ii) maintenance capital
expenditures, (iii) dividends received from investments in
associates and joint ventures, (iv) interest on leases and
long-term debt, and (v) payments on principal amounts on leases.
Available cash flow per share is calculated as Available cash flow
divided by the weighted average number of outstanding common
shares. See following table for a calculation of historical
Available cash flow and Available cash flow per share and a
reconciliation to cash generated from (used in) operating
activities.
|
Three months
ended
|
Trailing twelve
months ended
December 31,
2023(4)
|
($ millions, unless
otherwise noted)
|
March 31,
2023
|
June 30,
2023(1)
|
September 30,
2023
|
December 31,
2023
|
Cash generated from
(used in) operating activities
|
314
|
521
|
528
|
417
|
1,780
|
Reverse: Change in
other assets and other liabilities
|
11
|
(11)
|
7
|
(4)
|
3
|
Reverse: Net change in
non-cash working capital(2)
|
18
|
(145)
|
(14)
|
17
|
(124)
|
Include: Maintenance
capital expenditures attributable to
Parkland(4)
|
(79)
|
(61)
|
(52)
|
(93)
|
(285)
|
Include: Dividends
received from investments in associates and joint
ventures
|
16
|
2
|
4
|
3
|
25
|
Include: Interest on
leases and long-term debt
|
(92)
|
(89)
|
(83)
|
(88)
|
(352)
|
Include: Payments of
principal amount on leases
|
(51)
|
(56)
|
(57)
|
(71)
|
(235)
|
Available cash
flow
|
137
|
161
|
333
|
181
|
812
|
Weighted average number
of common shares (millions)(3)
|
|
|
|
|
176
|
Available cash flow per
share
|
|
|
|
|
4.61
|
|
Three months
ended
|
Trailing
twelve
months
ended
December 31,
2022(4)
|
($ millions, unless
otherwise noted)
|
March 31,
2022
|
June 30,
2022
|
September 30,
2022
|
December 31,
2022
|
Cash generated from
(used in) operating activities
|
(48)
|
341
|
404
|
629
|
1,326
|
Exclude: Adjusted
EBITDA attributable to NCI, net of tax
|
(26)
|
(27)
|
(11)
|
—
|
(64)
|
|
(74)
|
314
|
393
|
629
|
1,262
|
Reverse: Change in
other assets and other liabilities
|
(2)
|
(1)
|
23
|
(23)
|
(3)
|
Reverse: Net change in
non-cash working capital
|
420
|
88
|
(132)
|
(232)
|
144
|
Include: Maintenance
capital expenditures attributable to
Parkland(4)
|
(29)
|
(44)
|
(62)
|
(118)
|
(253)
|
Include: Dividends
received from investments in associates and joint
ventures
|
—
|
12
|
5
|
—
|
17
|
Include: Interest on
leases and long-term debt
|
(64)
|
(69)
|
(76)
|
(86)
|
(295)
|
Exclude: Interest on
leases and long-term debt attributable to NCI
|
1
|
1
|
—
|
—
|
2
|
Include: Payments on
principal amount on leases
|
(37)
|
(38)
|
(50)
|
(52)
|
(177)
|
Exclude: Payments on
principal amount on leases attributable to NCI
|
5
|
4
|
2
|
—
|
11
|
Available cash
flow
|
220
|
267
|
103
|
118
|
708
|
Weighted average number
of common shares (millions)(3)
|
|
|
|
|
160
|
Available cash flow per
share
|
|
|
|
|
4.43
|
(1)
|
For comparative
purposes, certain amounts within net change in non-cash working
capital for the three months ended June 30, 2023 were revised to
conform to the current period presentation.
|
(2)
|
Starting in the fourth
quarter of 2023, "Changes in risk management and other" are
included within net changes in non-cash working capital. For
comparative purposes, certain amounts within net change in non-cash
working capital were revised to conform to the current period
presentation.
|
(3)
|
Weighted average number
of common shares disclosed is consistent with the Note 3 of the
Annual Consolidated Financial Statements.
|
(4)
|
Supplementary financial
measure. See Section 17 of the Q4 2023 MD&A.
|
Return on Invested Capital ("ROIC") is a non-GAAP ratio and is
composed of Net operating profit after tax ("NOPAT") divided by
average invested capital. NOPAT describes the profitability of
Parkland's base operations, excluding the impact of leverage and
certain other items of income and expenditure that are not
considered representative of Parkland's underlying core operating
performance. NOPAT is based on Adjusted EBITDA including NCI, less
depreciation expense and the estimated tax expense using the
expected average tax rate estimated using statutory tax rates in
each jurisdiction where Parkland operates. Average invested capital
is the amount of capital deployed by Parkland that represents the
average of opening and closing debt and shareholder's equity,
including equity reserves, net of cash and cash equivalents. ROIC
is used by management to assess the Company's efficiency in
investing capital. The most directly comparable financial measure
to ROIC is net earnings. See following table for a calculation of
historical ROIC for 2022 and 2023, the calculation of NOPAT and the
reconciliation to net earnings and the calculation of invested
capital.
|
Trailing twelve
months
ended December 31,
|
ROIC
|
2023
|
2022
|
Net earnings
(loss)
|
471
|
346
|
Add/(less):
|
|
|
Income tax expense
(recovery)
|
37
|
70
|
Acquisition,
integration and other costs
|
146
|
117
|
Depreciation and
amortization
|
823
|
743
|
Finance cost
|
384
|
331
|
Unrealized foreign
exchange (gain) loss
|
35
|
(8)
|
Unrealized loss (gain)
on risk management and other
|
(34)
|
39
|
Other (gains) and
losses
|
3
|
23
|
Other adjusting
items
|
48
|
26
|
Adjusted EBITDA
including NCI
|
1,913
|
1,687
|
Less:
Depreciation
|
(823)
|
(743)
|
Adjusted
EBIT
|
1,090
|
944
|
Average effective tax
rate
|
16.7 %
|
22.5 %
|
Less: Taxes
|
(182)
|
(212)
|
Net operating profit
after tax
|
908
|
732
|
Opening invested
capital
|
9,293
|
8,151
|
Closing invested
capital
|
9,152
|
9,293
|
Average invested
capital
|
9,223
|
8,722
|
Return on invested
capital
|
9.8 %
|
8.4 %
|
Invested
capital
|
December 31,
|
($ millions, unless
otherwise noted)
|
2023
|
2022
|
2021
|
Long-term debt -
current portion
|
191
|
173
|
124
|
Long-term
debt
|
6,167
|
6,799
|
5,432
|
Shareholders'
equity
|
3,181
|
3,037
|
2,332
|
Sol Put
Option
|
—
|
—
|
589
|
Exclude: Cash and cash
equivalents
|
(387)
|
(716)
|
(326)
|
Total
|
9,152
|
9,293
|
8,151
|
The non-GAAP financial measures and ratios should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS. Except as otherwise
indicated, these non-GAAP measures and ratios are calculated and
disclosed on a consistent basis from period to period. See Section 17 of the Q4 2023 MD&A, which is
incorporated by reference into this news release, for further
details regarding Parkland's non-GAAP financial measures and
ratios.
Capital Management Measures
Parkland's primary capital management measure is the Leverage
Ratio, which is used internally by key management personnel to
monitor Parkland's overall financial strength, capital structure
flexibility, and ability to service debt and meet current and
future commitments. The Leverage Ratio is calculated as a ratio of
Leverage Debt to Leverage EBITDA (each as defined in the 2023
Annual Consolidated Financial Statements) and does not have any
standardized meaning prescribed under IFRS. It is therefore
unlikely to be comparable to similar measures presented by other
companies. See Section 17 of the Q4
2023 MD&A, which is incorporated by reference into this news
release, for further details regarding capital management measures
used by Parkland.
|
December 31,
2023
|
December 31,
2022
|
Leverage
Debt
|
4,976
|
5,480
|
Leverage
EBITDA
|
1,780
|
1,602
|
Leverage
Ratio
|
2.8
|
3.4
|
|
December 31,
2023
|
December 31,
2022
|
Long-term
debt
|
6,358
|
6,972
|
Less:
|
|
|
Lease
obligations
|
(1,048)
|
(828)
|
Cash and cash
equivalents
|
(387)
|
(716)
|
Add:
|
|
|
Letters of
credit
|
53
|
52
|
Leverage
Debt
|
4,976
|
5,480
|
|
Three months
ended
|
Trailing twelve
months ended
December 31, 2023
|
|
March 31,
2023
|
June 30,
2023
|
September 30,
2023
|
December 31,
2023
|
Adjusted EBITDA
including NCI
|
395
|
470
|
585
|
463
|
1,913
|
Share incentive
compensation
|
8
|
6
|
5
|
11
|
30
|
Reverse: IFRS 16
impact(1)
|
(61)
|
(68)
|
(71)
|
(82)
|
(282)
|
|
342
|
408
|
519
|
392
|
1,661
|
Other
adjustments(2)
|
|
|
|
|
119
|
Leverage
EBITDA
|
|
|
|
|
1,780
|
(1)
|
Includes the impact of
operating leases prior to the adoption of IFRS 16, previously
recognized under operating costs, which aligns with management's
view of the impact to earnings.
|
(2)
|
Adjustments to
normalize EBITDA in relation to non-recurring events including the
completion of turnarounds and third-party power outages.
|
|
Three months
ended
|
Trailing twelve
months ended
December 31, 2022
|
|
March 31,
2022
|
June 30,
2022
|
September 30,
2022
|
December 31,
2022
|
Adjusted EBITDA
including NCI
|
414
|
478
|
340
|
455
|
1,687
|
Share incentive
compensation
|
9
|
5
|
7
|
9
|
30
|
Reverse: IFRS 16
impact(1)
|
(44)
|
(46)
|
(49)
|
(58)
|
(197)
|
|
379
|
437
|
298
|
406
|
1,520
|
Acquisition pro-forma
adjustment(2)
|
|
|
|
|
51
|
Other
adjustments(3)
|
|
|
|
|
31
|
Leverage
EBITDA
|
|
|
|
|
1,602
|
(1)
|
Includes the impact of
operating leases prior to the adoption of IFRS 16, previously
recognized under operating costs, which aligns with management's
view of the impact to earnings.
|
(2)
|
Amounts for the
trailing twelve months ended December 31, 2022 include the
impact of pro-forma pre-acquisition EBITDA estimates based on
anticipated benefits, costs and synergies from
acquisitions.
|
(3)
|
Adjustments to
normalize EBITDA in relation to non-recurring events including the
completion of turnarounds, mechanical break-downs, and third-party
power outages.
|
Total of Segments Measures
Adjusted EBITDA is a total of segments measure used by the chief
operating decision maker to make decisions about resource
allocation to the segment and to assess its performance. In
accordance with IFRS, adjustments and eliminations made in
preparing an entity's financial statements and allocations of
revenue, expenses, and gains or losses shall be included in
determining reported segment profit or loss only if they are
included in the measure of the segment's profit or loss that is
used by the chief operating decision maker. As such, Parkland's
Adjusted EBITDA is unlikely to be comparable to similarly named
measures presented by other issuers, who may calculate these
measures differently. Parkland views Adjusted EBITDA as the key
measure for the underlying core operating performance of business
segment activities at an operational level. Adjusted EBITDA is used
by management to set targets for Parkland (including annual
guidance and variable compensation targets) and is used to
determine Parkland's ability to service debt, finance capital
expenditures and provide for dividend payments to shareholders.
See Section 17 of the Q4 2023
MD&A, which is incorporated by reference into this news
release, for further details regarding total of segments measures
used by Parkland. Refer to the table below for the reconciliation
of Adjusted EBITDA to net earnings (loss) for the three months and
year ended December 31, 2023 and
December 31, 2022.
|
Three months ended
December 31,
|
Year ended
December 31,
|
($ millions)
|
2023
|
2022
|
2023
|
2022
|
Adjusted EBITDA
attributable to Parkland ("Adjusted EBITDA")
|
463
|
455
|
1,913
|
1,620
|
Add: Attributable to
NCI
|
—
|
—
|
—
|
67
|
Adjusted EBITDA
including NCI
|
463
|
455
|
1,913
|
1,687
|
Less/(add):
|
|
|
|
|
Acquisition,
integration and other costs
|
42
|
41
|
146
|
117
|
Depreciation and
amortization
|
222
|
212
|
823
|
743
|
Finance
costs
|
89
|
94
|
384
|
331
|
(Gain) loss on foreign
exchange – unrealized
|
—
|
8
|
35
|
(8)
|
(Gain) loss on risk
management and other – unrealized
|
28
|
9
|
(34)
|
39
|
Other (gains) and
losses(1)
|
5
|
(21)
|
3
|
23
|
Other adjusting
items(2)
|
6
|
21
|
48
|
26
|
Income tax expense
(recovery)
|
(15)
|
22
|
37
|
70
|
Net earnings
(loss)
|
86
|
69
|
471
|
346
|
Net earnings (loss)
attributable to Parkland
|
86
|
69
|
471
|
310
|
Net earnings (loss)
attributable to NCI
|
—
|
—
|
—
|
36
|
(1)
|
Other (gains) and
losses for the three months ended December 31, 2023 include the
following: (i) $25 million loss (2022 - $13 million gain) in
Others, including nil (2022 - $19 million gain) in relation to
changes in redemption value of the Sol Put Option, which was
de-recognized on Parkland's acquisition of the remaining 25% of the
issued and outstanding shares in Sol in the Share Exchange on
October 18, 2022; (ii) $11 million non-cash valuation
loss (2022 - $6 million gain) due to the change in estimates of
environmental provision; (iii) $14 million non-cash valuation gain
(2022 - $2 million loss) due to the change in fair value of
redemption options; (iv) $15 million gain (2022 - $2 million gain)
on disposal of assets; and (v) $2 million gain (2022 - $2 million)
in Other income. Other (gains) and losses for the year ended
December 31, 2023 include the following: (i) $57 million loss (2022
- $23 million gain) in Others, including $27 million associated
with the write-off of certain assets related to the renewable
diesel complex, and nil (2022 - $30 million gain) in relation to
changes in redemption value of the Sol Put Option, which was
de-recognized on Parkland's acquisition of the remaining 25% of the
issued and outstanding shares in Sol on October 18, 2022;
(ii) $14 million loss (2022 - $17 million gain) due to
the change in estimates of environmental provision; (iii) $31
million non-cash valuation gain (2022 - $67 million loss) due to
the change in fair value of redemption options; (iv) $23 million
gain (2022 - $7 million gain) in Other income; and
(v) $14 million gain (2022 - $3 million loss) on disposal
of assets. Refer to Note 23 of the Annual Consolidated
Financial Statements.
|
(2)
|
Other adjusting items
for the three months ended December 31, 2023 include: (i) the share
of depreciation, income taxes and other adjustments for investments
in joint ventures and associates of $9 million (2022 - $2 million);
(ii) other income of $2 million (2022 - $4 million); (iii) realized
risk management gain related to underlying physical sales activity
in another period of $2 million (2022 - $7 million loss); (iv)
impact of hyperinflation accounting of $2 million loss (2022 - $1
million gain); (v) adjustment to foreign exchange gains and losses
related to cash pooling arrangements of $1 million (2022 - $1
million); (vi) unrealized risk management gain related to
underlying physical sales activity in current period of nil (2022 -
$10 million); and (vii) loss on inventory write-downs for
which there are offsetting associated risk management derivatives
with unrealized gains of nil (2022 - $2 million). Other adjusting
items for the year ended December 31, 2023 include: (i) other
income of $23 million (2022 - $8 million); (ii) the share of
depreciation, income taxes and other adjustments for investments in
joint ventures and associates of $20 million (2022 - $11 million);
(iii) the effect of market-based performance conditions for
equity-settled share-based award settlements of $13 million (2022 -
nil); (iv) realized risk management gain related to underlying
physical sales activity in another period of $6 million (2022 - $4
million loss); (v) impact of hyperinflation accounting of $2
million loss (2022 - $1 million gain); and (vi) adjustment to
foreign exchange gains and losses related to cash pooling
arrangements of nil (2022 - $2 million).
|
Parkland uses Adjusted gross margin as a measure of segment
profit (loss) to analyze the performance of sale and purchase
transactions and performance on margin. The most directly
comparable financial measure is sales and operating revenue.
See Section 17 of the Q4 2023
MD&A, which is incorporated by reference into this news
release, for the detailed definition of Adjusted gross margin.
Refer to the table below for a detailed calculation of Adjusted
gross margin for the three months and year ended December 31, 2023 and December 31, 2022.
|
Three months ended
December 31,
|
Year ended
December 31,
|
($ millions)
|
2023
|
2022
|
2023
|
2022
|
Sales and operating
revenue
|
7,746
|
8,719
|
32,452
|
35,462
|
Cost of
purchases
|
(6,850)
|
(7,682)
|
(28,484)
|
(31,441)
|
Gain (loss) on risk
management and other -- realized
|
122
|
(56)
|
51
|
(336)
|
Gain (loss) on foreign
exchange -- realized
|
2
|
(1)
|
(7)
|
(16)
|
Other adjusting items
to Adjusted gross margin(1)
|
(8)
|
15
|
(11)
|
7
|
Adjusted gross
margin
|
1,012
|
995
|
4,001
|
3,676
|
Fuel and petroleum
product adjusted gross margin
|
814
|
807
|
3,254
|
3,013
|
Food, convenience and
other adjusted gross margin
|
198
|
188
|
747
|
663
|
Adjusted gross
margin
|
1,012
|
995
|
4,001
|
3,676
|
(1)
|
Other adjusting items
to Adjusted gross margin for the three months ended December 31,
2023 include (i) impact of hyperinflation accounting of $5 million
loss (2022 - $1 million gain); (ii) realized risk management gain
related to underlying physical sales activity in another period of
$2 million (2022 - $7 million loss); (iii) adjustment to foreign
exchange gains and losses related to cash pooling arrangements of
$1 million (2022 - $1 million); (iv) unrealized risk management
gain related to underlying physical sales activity in current
period of nil (2022 - $10 million); and (v) loss on inventory
write-downs for which there are offsetting associated risk
management derivatives with unrealized gains of nil (2022 - $2
million). Other adjusting items to Adjusted gross margin for the
year ended December 31, 2023 include (i) realized risk management
gain related to underlying physical sales activity in another
period of $6 million (2022 - $4 million loss); (ii) impact of
hyperinflation accounting of $5 million loss (2022 - $1 million
gain); and (iii) adjustment to foreign exchange gains and losses
related to cash pooling arrangements of nil (2022 - $2
million).
|
|
|
Supplementary Financial Measures
Parkland uses a number of supplementary financial measures,
including Adjusted EBITDA Guidance, liquidity available, TTM Cash
generated from (used in) operating activities, and TTM Cash
generated from (used in) operating activities per share, and these
measures may not be comparable to similar measures presented by
other issuers, as other issuers may calculate these measures
differently. See Section 17 of the
Q4 2023 MD&A, which is incorporated by reference into this news
release, for further details regarding supplementary financial
measures used by Parkland, including the composition of such
measures.
Non-Financial Measures
Parkland uses a number of non-financial measures, including
composite utilization and total recordable injury frequency rate,
in measuring the success of our strategic objectives and to set
variable compensation targets for employees. These non-financial
measures are not accounting measures, do not have
comparable IFRS measures, and may not be comparable to
similar measures presented by other issuers, as other issuers may
calculate these metrics differently. See
Section 17 of the Q4 2023 MD&A, which is incorporated by
reference into this news release, for further details on the
non-financial measures used by Parkland.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/parkland-reports-strong-2023-fourth-quarter-and-record-year-end-results-increases-dividend-for-the-twelfth-consecutive-year-302073357.html
SOURCE Parkland Corporation